Blood Test Predicts the Effect of Palbociclib Drug on Breast Cancer Patients
A blood test can evaluate the effect of the palbociclib drug on breast cancer patients. The test identifies the circulating tumor DNA fragment in the bloodstream, which is shed by the cancer cells.
Read More